Sponsor or institution
Clinical trials and research at Huai'an First People's Hospital
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Huai'an First People's Hospital that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Orelabrutinib and Obinutuzumab for Treating Marginal Zone Lymphoma
This study is testing a new treatment combining Orelabrutinib and Obinutuzumab for people with previously untreated Marginal Zone Lymphoma to see if it works better and is safer than traditional chemotherapy.
-
Treatment for acute myeloid leukemia with KMT2A gene abnormalities using VHEA.
This study is testing a new combination of medications to see if it can help people with acute myeloid leukemia that has KMT2A gene abnormalities feel better and improve their chances of recovery.
Quick answers
How many clinical trials run by Huai'an First People's Hospital are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.